Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 13, 2008, Pages 3737-3740

  Sparatore, Anna ^a   Basilico, Nicoletta ^a   Casagrande, Manolo ^a   Parapini, Silvia ^a   Taramelli, Donatella ^a   Brun, Reto ^b   Wittlin, Sergio ^b   Sparatore, Fabio ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c CTG Pharma   (Italy)

Author keywords

4 Aminoquinoline derivatives; Antimalarial agents; Chloroquine; Pyrrolizidinyl derivatives

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; CHLOROQUINE; PYRROLIZIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; BODY WEIGHT; CELL LINE; CHLOROQUINE; HUMANS; MALARIA; MICE; MICROSOMES; MODELS, CHEMICAL; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PYRROLES;

MAMMALIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 44749091704     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.05.042     Document Type: Article

References (22)

1. O'Neill P.M., Ward S.A., Berry N.G., Jeyadevan J.P., Biagini G.A., Asadollaly E., Park B.K., and Bray P.G. Curr. Top. Med. Chem. 6 (2006) 479
2. Sparatore A., Basilico N., Parapini S., Romeo S., Novelli F., Sparatore F., and Taramelli D. Bioorg. Med. Chem. 13 (2005) 5338
3. Lucantoni, L.; Sparatore, A.; Basilico, N.; Parapini, S.; Yardley, V.; Stewart, L.; Habluetzel, A.; Pasqualini, L.; Esposito, F.; Taramelli, D. In: Third Cost B22 Annual Congress 'Drug discovery and development for parasitic diseases', Athens, 1-4 October 2006, Book of abstracts, p. 137.
4. Miyano S., Sumoto K., Satoh F., Shima K., Hayashimatsu M., Morita M., Aisaka K., and Noguchi T. J. Med. Chem. 28 (1985) 714
5. Oka M., Matsumoto Y., Hirooka K., and Suzuki T. Chem. Pharm. Bull. 48 (2000) 1121
6. Suzuki T., Usui T., Oka M., Suzuki T., and Kataoka T. Chem. Pharm. Bull. 45 (1998) 1265
7. Suzuki T., Oka M., Maeda K., Furusawa K., Uesaka H., and Takaoka T. Chem. Pharm. Bull. 47 (1999) 28
8. Takeda M., Tsukamoto K., Yamano M., and Uesaka H. Jpn. J. Pharmacol. (1999) 292
9. + 302.14185, found 302.14187.
10. Miyano S., Yamashita O., Sumoto K., Shima K., Hayashimatsu M., and Satoh F. J. Heterocycl. Chem. 24 (1987) 271
11. Miyano S., Yamashita O., Sumoto K., Shima K., Hayashimatsu M., and Satoh F. J. Heterocycl. Chem. 24 (1987) 47
12. Oka M., Baba K., Nakamura L., Dong L., Hamajima H., Unno R., and Matsumoto Y. J. Heterocycl. Chem. 40 (2003) 177
13. Oka M., Baba K., Suzuki T., and Masumoto Y. Heterocycles 45 (1997) 2317
14. Makler M.T., Ries J.M., Williams J.A., Bancroft J.E., Piper R.C., Gibbins B.L., and Hinrichs D.J. Am. J. Trop. Med. Hyg. 48 (1993) 739
15. Desjardins R.E., Canfield C.J., Haynes J.D., and Chulay J.D. Antimicrob. Agents Chemother. 16 (1979) 710
16. Parapini S., Basilico N., Pasini E., Egan T.J., Olliaro P., and Taramelli D. Exp. Parasitol. 96 (2000) 249
17. D'Alessandro S., Gelati M., Basilico N., Parati E.A., Haynes R.K., and Taramelli D. Toxicology 241 (2007) 66
18. Donation from A. P. Waters and C. J. Janse, Leiden University.
19. Ridley R.G., Matile H., Jaquet C., Dorn A., Hofheinz W., Leupin W., Masciadri R., Theil F.P., Richter W.F., Girometta M.A., Guenzi A., Urwyler H., Gocke E., Potthast J.M., Csato M., Thomas A., and Peters W. Antimicrob. Agents Chemother. 41 (1997) 677
20. Peters W. Chemotherapy and Drug Resistance in Malaria Vol. 1 (1987), Academic Press, London pp 97-174
21. 2 3 mM and UDPGA 1 mM); samples were taken at time 0 and 30 min and added to acetonitrile to stop reaction, centrifuged and supernatant analyzed by LC-MS/MS (PremiereXE, Waters, in full scan ESI pos mode). Acquired data were processed by Metabolynx software. A control sample without cofactor was always added in order to check the chemical stability of test compound. 7-Ethoxycoumarin was used as reference standard.
22. 50 (concentration at 50% inhibition) is then determined by using Grafit v. 6.0.